Antimicrobial Agents Practice Questions

Q: On which of the following does pyrazinamide act?

Tuberculous bacilli in macrophages. **Explanation:** Pyrazinamide (PZA) is a critical first-line anti-tubercular drug known for its unique ability to target **intracellular mycobacteria** residing within macrophages. **1. Why Option C is Correct:** Pyrazinamide is a prodrug converted into its active form, **pyrazinoic acid**, by the enzyme *nicotinamidase (pyrazinamidase)*. This conversion occurs most efficiently in **acidic environments** (pH 5.0–5.5). In the body, such acidic conditions are found specifically within the **phagolysosomes of macrophages**. Therefore, PZA is highly effective against "slowly multiplying" intracellular bacilli that other drugs (like Streptomycin) cannot reach. This makes it a potent **sterilizing agent**, crucial for shortening the duration of TB treatment from 9 months to 6 months. **2. Why Other Options are Incorrect:** * **Option A:** This describes the mechanism of **Sulfonamides** or **Para-aminosalicylic acid (PAS)**, which inhibit dihydropteroate synthase. * **Option B:** Pyrazinamide is primarily **bactericidal**, not bacteriostatic, particularly in acidic environments. It targets dormant/persistent organisms rather than rapidly growing ones. * **Option D:** Bacilli in the bloodstream or in well-oxygenated extracellular cavities are usually in a neutral or alkaline environment. PZA has negligible activity at physiological pH (7.4); drugs like **Isoniazid** and **Rifampin** are more effective here. **High-Yield Clinical Pearls for NEET-PG:** * **Most common side effect:** Hyperuricemia (due to inhibition of uric acid excretion), which may precipitate **acute gouty arthritis**. * **Most serious side effect:** Hepatotoxicity (dose-dependent). * **Resistance:** Occurs due to mutations in the **pncA gene**, which encodes the pyrazinamidase enzyme. * **Role in RNTCP:** It is used only in the **Intensive Phase** (first 2 months) of Short-Course Chemotherapy.

Q: What is the recommended prophylaxis for H1N1 influenza?

Oseltamivir. **Explanation:** **Oseltamivir (Option A)** is the drug of choice for both the treatment and prophylaxis of H1N1 influenza. It belongs to the **Neuraminidase Inhibitors** class. Neuraminidase is an enzyme essential for the release of newly formed viral particles from infected host cells; by inhibiting this enzyme, Oseltamivir prevents the spread of the virus within the respiratory tract. It is preferred for prophylaxis because it is administered **orally**, making it convenient for outpatient use and mass distribution during outbreaks. **Why other options are incorrect:** * **Zanamivir (Option B):** While also a neuraminidase inhibitor effective against H1N1, it is administered via **inhalation**. This makes it unsuitable for patients with underlying airway diseases (like asthma or COPD) due to the risk of bronchospasm, and less practical for general prophylaxis compared to oral Oseltamivir. * **Amantadine and Rimantadine (Options C & D):** These are **M2 ion channel blockers**. They are only effective against Influenza A and have no activity against Influenza B. More importantly, most current strains of H1N1 have developed widespread high-level resistance to these drugs, rendering them obsolete for H1N1 prophylaxis. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** For effective prophylaxis, Oseltamivir should ideally be started within **48 hours** of exposure. * **Pregnancy:** Oseltamivir is considered the safest antiviral for pregnant women with H1N1. * **Side Effects:** The most common side effects of Oseltamivir are nausea and vomiting (taking it with food helps). * **Baloxavir Marboxil:** A newer drug (Cap-dependent endonuclease inhibitor) is now used for treatment but Oseltamivir remains the standard for prophylaxis in most guidelines.

Q: The antiviral drug recommended for treatment of Herpes Zoster infection of Trigeminal nerve distribution in an immunocompromised host is?

Famciclovir. **Explanation:** The clinical scenario describes **Herpes Zoster (Shingles)** involving the trigeminal nerve (Ophthalmic division involvement can lead to Herpes Zoster Ophthalmicus) in an **immunocompromised host**. In such cases, prompt and potent antiviral therapy is mandatory to prevent complications like post-herpetic neuralgia or ocular damage. **Why Famciclovir is correct:** Famciclovir is a prodrug of penciclovir. It is highly effective against Varicella-Zoster Virus (VZV). In immunocompromised patients, oral **Famciclovir** or **Valacyclovir** are preferred over Acyclovir due to their superior bioavailability and less frequent dosing schedules. They achieve higher intracellular concentrations, which is crucial for treating aggressive VZV infections in high-risk patients. **Analysis of Incorrect Options:** * **A. Fomivirsen:** This is an antisense oligonucleotide used specifically for the local (intravitreal) treatment of **CMV retinitis** in HIV patients. It is not used for VZV. * **B. Vidarabine:** An older antiviral (Adenine Arabinoside) that was used for Herpes Simplex Encephalitis. It is rarely used today due to high systemic toxicity compared to modern alternatives like Acyclovir. * **D. Entecavir:** This is a potent nucleoside analog used specifically for the treatment of **Chronic Hepatitis B** infection. It has no clinical utility against the Herpes virus family. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** For Herpes Zoster in immunocompromised patients, the DOC is **Intravenous Acyclovir** if the infection is severe/disseminated; however, for stable patients, **Famciclovir** or **Valacyclovir** are the preferred oral agents. * **Mechanism:** Famciclovir requires viral **Thymidine Kinase** for initial phosphorylation (activation). * **Post-Herpetic Neuralgia (PHN):** Early administration of Famciclovir (within 72 hours) significantly reduces the duration and severity of PHN.

Q: Lamivudine acts against which of the following viruses?

Both HIV and HBV. **Explanation:** Lamivudine (3TC) is a nucleoside analog that acts as a potent inhibitor of the enzyme **Reverse Transcriptase**. Its mechanism involves being phosphorylated intracellularly into its active triphosphate form, which then competes with natural nucleotides for incorporation into viral DNA, leading to **obligate chain termination**. **Why Option C is Correct:** * **HIV:** Lamivudine is a cornerstone of Highly Active Antiretroviral Therapy (HAART). It belongs to the **NRTI (Nucleoside Reverse Transcriptase Inhibitor)** class and is effective against both HIV-1 and HIV-2. * **HBV:** The Hepatitis B Virus, though a DNA virus, utilizes a reverse transcription step in its replication cycle (via HBV DNA polymerase). Lamivudine effectively inhibits this enzyme, making it one of the first oral drugs approved for chronic Hepatitis B. **Why other options are incorrect:** * **Options A & B:** These are partially correct but incomplete. Since Lamivudine is clinically indicated and FDA-approved for both infections, "Both" is the most accurate choice for a competitive exam. **High-Yield Clinical Pearls for NEET-PG:** * **Dosing Difference:** The dose of Lamivudine required for HBV (100 mg/day) is lower than that required for HIV (300 mg/day). * **M184V Mutation:** This is the specific high-level resistance mutation associated with Lamivudine in HIV treatment. * **Safety:** It is one of the least toxic NRTIs; however, it can cause a "flare-up" of Hepatitis B if discontinued abruptly in co-infected patients. * **Pregnancy:** It is considered safe and is frequently used to prevent vertical transmission of HIV.

Q: Which third-generation cephalosporin can be administered orally?

Cefixime. ### Explanation **Correct Answer: A. Cefixime** **1. Why Cefixime is correct:** Cephalosporins are classified into generations based on their chronological development and spectrum of activity. **Cefixime** is a prototype **third-generation cephalosporin** that is characterized by its stability against many beta-lactamases and its availability as an **oral formulation**. It is highly effective against Gram-negative organisms (like *H. influenzae* and *M. catarrhalis*) but has limited activity against *S. aureus*. **2. Analysis of Incorrect Options:** * **B. Cefpirome:** This is a **fourth-generation** cephalosporin. It is highly resistant to beta-lactamases and is administered only via the parenteral (IV/IM) route for serious hospital-acquired infections. * **C. Cefaclor:** This is a **second-generation** cephalosporin. While it is administered orally, it belongs to an earlier generation with a different spectrum of activity (better Gram-positive coverage than 3rd gen). * **D. Cefadroxil:** This is a **first-generation** cephalosporin. It is an oral agent primarily used for skin and soft tissue infections caused by Gram-positive cocci. **3. NEET-PG High-Yield Pearls:** * **Oral 3rd Gen Cephalosporins:** Besides Cefixime, other oral options include **Cefpodoxime proxetil**, **Ceftibuten**, and **Cefdinir**. * **Cefixime Clinical Use:** It is a drug of choice for oral treatment of uncomplicated urinary tract infections and was traditionally used for gonorrhea (though resistance is increasing). * **Excretion:** Unlike most cephalosporins which are renally excreted, **Ceftriaxone** (3rd gen) is primarily excreted through bile and does not require dose adjustment in renal failure. * **Anti-Pseudomonal 3rd Gen:** **Ceftazidime** and **Cefoperazone** are the third-generation agents with specific activity against *Pseudomonas aeruginosa*.

Q: What are the common complications associated with zidovudine therapy?

Nausea and vomiting. **Explanation:** **Zidovudine (AZT)** is a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in the management of HIV. Understanding its side effect profile is crucial for NEET-PG, as it distinguishes between "common" and "dose-limiting" toxicities. 1. **Why Option A is Correct:** **Nausea and vomiting** are the most **common** (frequent) side effects of zidovudine, occurring in approximately 25% of patients, especially during the first few weeks of therapy. These gastrointestinal symptoms are usually self-limiting and diminish as the body adjusts to the medication. 2. **Why Other Options are Incorrect:** * **B. Anemia:** While zidovudine is notorious for causing bone marrow suppression (anemia and neutropenia), this is considered the most important **dose-limiting** toxicity rather than the most common initial complaint. * **C. Steatosis:** Lactic acidosis with hepatic steatosis is a class-wide adverse effect of NRTIs due to mitochondrial toxicity. While serious, it is less common than acute GI distress. * **D. Nephrotoxicity:** Zidovudine is primarily metabolized by the liver (glucuronidation). Nephrotoxicity is more characteristic of other HIV drugs like **Tenofovir** (Fanconi-like syndrome) or Indinavir (crystalluria). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Zidovudine:** "Z" for **Z**eroing out the marrow (Anemia/Neutropenia). * **Drug of Choice:** Zidovudine is the preferred agent for preventing **mother-to-child transmission (MTCT)** of HIV during pregnancy and labor. * **Nail Hyperpigmentation:** A unique, high-yield physical finding associated with chronic zidovudine use. * **MCV Change:** An increase in Mean Corpuscular Volume (macrocytosis) is a common surrogate marker for patient compliance with zidovudine.

Q: What is the drug of choice for Chlamydia in pregnancy?

Erythromycin. **Explanation:** The drug of choice for treating *Chlamydia trachomatis* infections during pregnancy is **Erythromycin** (or alternatively, Azithromycin). **1. Why Erythromycin is Correct:** Chlamydia is an obligate intracellular bacterium that lacks a peptidoglycan cell wall, making it inherently resistant to beta-lactams. Macrolides like Erythromycin inhibit protein synthesis by binding to the 50S ribosomal subunit. In pregnancy, Erythromycin is considered safe (FDA Category B) and effective for preventing neonatal transmission (ophthalmia neonatorum) and maternal complications. While Azithromycin is now often preferred due to a single-dose regimen and better GI tolerance, Erythromycin remains a classic, established answer in standard textbooks and exams. **2. Why Other Options are Incorrect:** * **Doxycycline & Tetracycline:** These are the drugs of choice for Chlamydia in non-pregnant adults. However, they are **contraindicated in pregnancy** (Category D) because they cross the placenta and bind to calcium in fetal bones and teeth, leading to permanent dental discoloration and enamel hypoplasia. * **Penicillin:** As mentioned, Chlamydia lacks a typical cell wall structure. Penicillins target cell wall synthesis and are therefore clinically ineffective against this organism. **Clinical Pearls for NEET-PG:** * **Azithromycin** is currently the preferred macrolide in many guidelines due to better compliance (1g single dose). * **Neonatal Chlamydia:** Presents as inclusion conjunctivitis (5–14 days post-delivery) or interstitial pneumonia. * **Lymphogranuloma Venereum (LGV):** Caused by Chlamydia serotypes L1-L3; Doxycycline is the first-line treatment (except in pregnancy). * **Safe in Pregnancy Mnemonic:** "Many Antibiotics Can Be Safely Given" — **M**acrolides (Erythromycin/Azithromycin), **A**moxicillin, **C**ephalosporins, **B**eta-lactams, **S**pectinomycin, **G**entamicin (topical).

Q: Which of the following drugs is FDA-approved for the treatment of HIV?

Ibalizumab. ### Explanation **Correct Option: C. Ibalizumab** Ibalizumab is a first-in-class **post-attachment inhibitor**. It is a humanized monoclonal antibody that binds to domain 2 of the CD4 T-cell receptor. Unlike entry inhibitors like Maraviroc (which targets CCR5), Ibalizumab does not prevent HIV from binding to the CD4 cell; instead, it prevents the conformational changes required for the viral envelope to fuse with the host cell membrane. It was FDA-approved in 2018 for **multidrug-resistant (MDR) HIV-1** in treatment-experienced adults. **Incorrect Options:** * **A. Ivacaftor:** A CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) potentiator used in the treatment of **Cystic Fibrosis** (specifically for the G551D mutation). * **B. Apalutamide:** A second-generation **androgen receptor inhibitor** used in the management of non-metastatic castration-resistant prostate cancer. * **C. Eculizumab:** A monoclonal antibody that inhibits the **C5 complement protein**. It is used for Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS). **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Ibalizumab blocks "post-binding" steps required for viral entry. * **Route:** Administered via **intravenous (IV) infusion** every 2 weeks (unique among most ARVs). * **Indication:** Reserved for "salvage therapy" in patients failing their current antiretroviral regimen. * **Other Entry Inhibitors:** * *Maraviroc:* CCR5 Antagonist (requires Tropism testing). * *Enfuvirtide:* Fusion inhibitor (binds to gp41). * *Fostemsavir:* Attachment inhibitor (binds to gp120).

Question 1

What is the mechanism of action by which pyrantel pamoate is effective for the treatment of Necator americanus (hookworm) disease?

Accepted Answer

Inhibition of neuromuscular transmission

Answer

Interference with cell-wall synthesis

Answer

Interference with cell division

Answer

Depletion of membrane lipoproteins

Question 2

On which of the following does pyrazinamide act?

Accepted Answer

Tuberculous bacilli in macrophages

Answer

Interfering with folic acid biosynthesis of mycobacteria

Answer

Bacteriostatic activity on growing organisms

Answer

Tuberculous bacilli in the bloodstream

Question 3

What is the recommended prophylaxis for H1N1 influenza?

Accepted Answer

Oseltamivir

Answer

Zanamivir

Answer

Amantadine

Answer

Rimantadine

Question 4

The antiviral drug recommended for treatment of Herpes Zoster infection of Trigeminal nerve distribution in an immunocompromised host is?

Accepted Answer

Famciclovir

Answer

Fomivirsen

Answer

Vidarabin

Answer

Entecavir

Question 5

Lamivudine acts against which of the following viruses?

Accepted Answer

Both HIV and HBV

Answer

HIV

Answer

HBV

Answer

None of the above

Question 6

Which third-generation cephalosporin can be administered orally?

Accepted Answer

Cefixime

Answer

Cefpirome

Answer

Cefaclor

Answer

Cefadroxil

Question 7

What are the common complications associated with zidovudine therapy?

Accepted Answer

Nausea and vomiting

Answer

Anemia

Answer

Steatosis

Answer

Nephrotoxicity

Question 8

What is the drug of choice for Chlamydia in pregnancy?

Accepted Answer

Erythromycin

Answer

Doxycycline

Answer

Tetracycline

Answer

Penicillin

Question 9

Which of the following drugs is FDA-approved for the treatment of HIV?

Accepted Answer

Ibalizumab

Answer

Ivacaftor

Answer

Apalutamide

Answer

Eculizumab

Question 10

What is the treatment of choice for late cardiovascular syphilis?

Accepted Answer

Benzathine penicillin 7.2 million units in three divided doses

Answer

Benzathine penicillin 2.4 million units single dose

Answer

Benzyl penicillin 12-24 million units for 21 days

Answer

Tetracycline 2 g daily

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?